Michelle Lee-bourner

Michelle Lee-Bourner Mylan Pharma UK Ltd Head Global Respiratory and Biologics Regulatory Sciences Michelle Lee-Bourner has 30 years’ experience of drug pharmaceutical research and development, focused mainly on NCE’s and more recently generics, biosimilars and biologics. At Pfizer Michelle’s career spanned drug discovery, early clinical research and Regulatory Affairs. Michelle had the opportunity to join Mylan in 2011, where she leads Global Respiratory and Biologics Regulatory Development. Michelle has been a Board Member of IPAC-RS for the last 8 years. Michelle cites overseeing the regulatory development and approval of Generic Advair in the US (Wixela, Inhub) as one of her key achievements. Outside of work Michelle enjoys time with her teenagers, reading, skiing and sailing.